Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)
CIMA — Centro de Información de Medicamentos · Spain
- Updated
- Not provided for this source record
- Synchronized
- Oct 2, 2026
Medicine · Spain
CIPROFLOXACINO CINFA 250 MG COMPRIMIDOS RECUBIERTOS EFG
Tablet
Home Med Cabinet
Updated · Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) — Not provided for this source record
Synchronized
At a glance
- Active ingredient
- CIPROFLOXACINO HIDROCLORURO — 250 mg
- Pharmaceutical form Home Med Cabinet grouping
- Tablet
- Availability in Spain
- 1 of 3 packs marketed
Packs
CIPROFLOXACINO CINFA 250 MG COMPRIMIDOS RECUBIERTOS EFG , 14 comprimidos
14 pcs
National code
Marketed697017Strength of this pack 250 mg
CIPROFLOXACINO CINFA 250 MG COMPRIMIDOS RECUBIERTOS EFG , 10 comprimidos
10 pcs
National code
Not marketed796656Strength of this pack 250 mg
CIPROFLOXACINO CINFA 250 MG COMPRIMIDOS RECUBIERTOS EFG , 20 comprimidos
20 pcs
National code
Not marketed797118Strength of this pack 250 mg
“Marketed” means the authority records the pack as placed on the market. It is not a statement about pharmacy stock.
Official documents
Documents open on the authority’s own site. Home Med Cabinet links to them and hosts no copy.
- Official
Opens on the authority’s own site
- Official
Summary of product characteristics
Opens on the authority’s own site
Registration
- Registration number
- 62768Official data
- Marketing authorisation holder
- LABORATORIOS CINFA S.A.Official data
- Authorised
- Oct 1, 1999Official data
- Authority form code
- 41Official data
Classification
ATC classification is not published here yet
Publication rights for ATC codes and labels are still under review, and no classification is inferred for this record.